Recent Trends in Manufacturing Technology of Highly Potent Drugs

High Potent Active Pharmaceutical Ingredients (HPAPIs or HPAIs) compounds can present many challenges due to the complex handling required for toxic substances. The facilities, equipment and operational procedures for handling potent materials on a commercial scale must be designed, constructed, and proven to be safe before manufacturing can commence. This article addresses and briefly covers the recent trends in manufacturing of HPAPIs or HPAIs compounds and drug products.

Read more..
Recent Advances in Cancer Treatment

Cancer, a disease of uncontrolled growth of abnormal cells, is the second leading cause of death worldwide and accounted for about 9.6 million deaths in the year 2018. This blog reviews the advances made in cancer therapy over the years from non-specific chemotherapy to the more recent targeted and personalized treatments.

Read more..
COVID Update
Team IDRS is committed towards working on complex products in niche therapeutic areas to address the unmet medical needs. This extends to the current challenging time, where the entire scientific community is working towards bringing some therapeutic option to provide relief from Covid-19 and associated complications. Our team, in collaboration with some of the premier Indian Institutes, is fervently working on a phytopharmaceutical product that will not only provide an option to treat Covid 19 patients but also minimise post Covid complications. Watch this space for further updates.